{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:59:47Z","timestamp":1781085587131,"version":"3.54.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Variola and vaccinia viruses, the two most important members of the family Poxviridae, are known to encode homologs of the human complement regulators named smallpox inhibitor of complement enzymes (SPICE) and vaccinia virus complement control protein (VCP), respectively, to subvert the host complement system. Intriguingly, consistent with the host tropism of these viruses, SPICE has been shown to be more human complement-specific than VCP, and in this study we show that VCP is more bovine complement-specific than SPICE. Based on mutagenesis and mechanistic studies, we suggest that the major determinant for the switch in species selectivity of SPICE and VCP is the presence of oppositely charged residues in the central complement control modules, which help enhance their interaction with factor I and C3b, the proteolytically cleaved form of C3. Thus, our results provide a molecular basis for the species selectivity in poxviral complement regulators.<\/jats:p>","DOI":"10.4049\/jimmunol.1200946","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T18:29:32Z","timestamp":1340735372000},"page":"1431-1439","source":"Crossref","is-referenced-by-count":14,"title":["Species Selectivity in Poxviral Complement Regulators Is Dictated by the Charge Reversal in the Central Complement Control Protein Modules"],"prefix":"10.1093","volume":"189","author":[{"given":"Viveka Nand","family":"Yadav","sequence":"first","affiliation":[{"name":"National Centre for Cell Science, Pune University , Ganeshkhind, Pune 411007,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyani","family":"Pyaram","sequence":"additional","affiliation":[{"name":"National Centre for Cell Science, Pune University , Ganeshkhind, Pune 411007,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzammil","family":"Ahmad","sequence":"additional","affiliation":[{"name":"National Centre for Cell Science, Pune University , Ganeshkhind, Pune 411007,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Sahu","sequence":"additional","affiliation":[{"name":"National Centre for Cell Science, Pune University , Ganeshkhind, Pune 411007,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,1]]},"reference":[{"key":"2025032409214271300_r1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"key":"2025032409214271300_r2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijid.2004.09.004","article-title":"Smallpox: a disease and a weapon","volume":"8","author":"Alibek","year":"2004","journal-title":"Int. J. Infect. Dis."},{"key":"2025032409214271300_r3","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409214271300_r4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm1265","article-title":"Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases","volume":"11","author":"Reeves","year":"2005","journal-title":"Nat. Med."},{"key":"2025032409214271300_r5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/mr.55.1.80-122.1991","article-title":"Poxvirus pathogenesis","volume":"55","author":"Buller","year":"1991","journal-title":"Microbiol. Rev."},{"key":"2025032409214271300_r6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrmicro1099","article-title":"Poxvirus tropism","volume":"3","author":"McFadden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"2025032409214271300_r7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrmicro1824","article-title":"Complement evasion by human pathogens","volume":"6","author":"Lambris","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"2025032409214271300_r8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2217\/fvl.10.60","article-title":"Virus-complement interactions: an assiduous struggle for dominance","volume":"5","author":"Pyaram","year":"2010","journal-title":"Future Virol."},{"key":"2025032409214271300_r9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement: first of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2025032409214271300_r10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"key":"2025032409214271300_r11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat. Immunol."},{"key":"2025032409214271300_r12","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1073\/pnas.112220499","article-title":"Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement","volume":"99","author":"Rosengard","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409214271300_r13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0168-1702(94)00113-Q","article-title":"Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses","volume":"36","author":"Shchelkunov","year":"1995","journal-title":"Virus Res."},{"key":"2025032409214271300_r14","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.174.4.2143","article-title":"Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins","volume":"174","author":"Sfyroera","year":"2005","journal-title":"J. Immunol."},{"key":"2025032409214271300_r15","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1128\/JVI.01935-07","article-title":"Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation","volume":"82","author":"Yadav","year":"2008","journal-title":"J. Virol."},{"key":"2025032409214271300_r16","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.4049\/jimmunol.0901366","article-title":"Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity","volume":"183","author":"Liszewski","year":"2009","journal-title":"J. Immunol."},{"key":"2025032409214271300_r17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3201\/eid1307.061404","article-title":"Brazilian vaccinia viruses and their origins","volume":"13","author":"Trindade","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"2025032409214271300_r18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1073\/pnas.89.2.628","article-title":"Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence","volume":"89","author":"Isaacs","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409214271300_r19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.2237434","article-title":"Inhibition of the complement cascade by the major secretory protein of vaccinia virus","volume":"250","author":"Kotwal","year":"1990","journal-title":"Science"},{"key":"2025032409214271300_r20","doi-asserted-by":"crossref","first-page":"9128","DOI":"10.1128\/JVI.02677-09","article-title":"Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement","volume":"84","author":"Moulton","year":"2010","journal-title":"J. Virol."},{"key":"2025032409214271300_r21","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1128\/JVI.01474-10","article-title":"The vaccinia virus complement control protein modulates adaptive immune responses during infection","volume":"85","author":"Girgis","year":"2011","journal-title":"J. Virol."},{"key":"2025032409214271300_r22","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1016\/j.vaccine.2011.07.062","article-title":"Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity","volume":"29","author":"Bernet","year":"2011","journal-title":"Vaccine"},{"key":"2025032409214271300_r23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0167-5699(91)90005-E","article-title":"The control of homologous lysis","volume":"12","author":"Lachmann","year":"1991","journal-title":"Immunol. Today"},{"key":"2025032409214271300_r24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"2025032409214271300_r25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1399-3089.2005.00237.x","article-title":"\u201cHomologous restriction\u201d in complement lysis: roles of membrane complement regulators","volume":"12","author":"Morgan","year":"2005","journal-title":"Xenotransplantation"},{"key":"2025032409214271300_r26","doi-asserted-by":"crossref","first-page":"12382","DOI":"10.1128\/JVI.79.19.12382-12393.2005","article-title":"Identification of complement regulatory domains in vaccinia virus complement control protein","volume":"79","author":"Mullick","year":"2005","journal-title":"J. Virol."},{"key":"2025032409214271300_r27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-1759(87)80003-0","article-title":"A fluorimetric assay for native C3: the hemolytically active form of the third component of human complement","volume":"102","author":"Pangburn","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"2025032409214271300_r28","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.4049\/jimmunol.160.11.5596","article-title":"Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway","volume":"160","author":"Sahu","year":"1998","journal-title":"J. Immunol."},{"key":"2025032409214271300_r29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0145-305X(87)90006-1","article-title":"A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella","volume":"11","author":"Phipps","year":"1987","journal-title":"Dev. Comp. Immunol."},{"key":"2025032409214271300_r30","doi-asserted-by":"crossref","first-page":"23119","DOI":"10.1074\/jbc.M603085200","article-title":"Functional characterization of the complement control protein homolog of herpesvirus saimiri: Arg-118 is critical for factor I cofactor activities","volume":"281","author":"Singh","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2025032409214271300_r31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0161-5890(78)90004-4","article-title":"The alternative complement pathway in bovine serum: the isolation of a serum protein with factor B activity","volume":"15","author":"Pang","year":"1978","journal-title":"Immunochemistry"},{"key":"2025032409214271300_r32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2460\/ajvr.2003.64.989","article-title":"Isolation and characterization of factor I of the bovine complement system","volume":"64","author":"Menger","year":"2003","journal-title":"Am. J. Vet. Res."},{"key":"2025032409214271300_r33","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1110\/ps.03455604","article-title":"Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli","volume":"13","author":"White","year":"2004","journal-title":"Protein Sci."},{"key":"2025032409214271300_r34","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1128\/JVI.77.6.3878-3881.2003","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins","volume":"77","author":"Mullick","year":"2003","journal-title":"J. Virol."},{"key":"2025032409214271300_r35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0161-5890(86)90175-6","article-title":"A reexamination of the role of magnesium in the human alternative pathway of complement","volume":"23","author":"Pryzdial","year":"1986","journal-title":"Mol. Immunol."},{"key":"2025032409214271300_r36","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1128\/JVI.78.17.9446-9457.2004","article-title":"Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b","volume":"78","author":"Bernet","year":"2004","journal-title":"J. Virol."},{"key":"2025032409214271300_r37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/infdis\/166.6.1245","article-title":"Regulation of complement activity by vaccinia virus complement-control protein","volume":"166","author":"McKenzie","year":"1992","journal-title":"J. Infect. Dis."},{"key":"2025032409214271300_r38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1201\/b14212-6","volume-title":"The Human Complement System in Health and Disease.","author":"Lambris","year":"1998"},{"key":"2025032409214271300_r39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nri2231","article-title":"Complement driven by conformational changes","volume":"8","author":"Gros","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2025032409214271300_r40","doi-asserted-by":"crossref","first-page":"52386","DOI":"10.1074\/jbc.M304620200","article-title":"A corresponding tyrosine residue in the C2\/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases","volume":"278","author":"Kuttner-Kondo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2025032409214271300_r41","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1073\/pnas.0307200101","article-title":"Complement regulation at the molecular level: the structure of decay-accelerating factor","volume":"101","author":"Lukacik","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409214271300_r42","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","article-title":"Structure of complement fragment C3b-factor H and implications for host protection by complement regulators","volume":"10","author":"Wu","year":"2009","journal-title":"Nat. Immunol."},{"key":"2025032409214271300_r43","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1529\/biophysj.105.068130","article-title":"Immunophysical properties and prediction of activities for VCP and SPICE using molecular dynamics and electrostatics","volume":"90","author":"Zhang","year":"2006","journal-title":"Biophys. J."},{"key":"2025032409214271300_r44","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4049\/jimmunol.0903261","article-title":"Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi\u2019s sarcoma-associated herpesvirus","volume":"184","author":"Pyaram","year":"2010","journal-title":"J. Immunol."},{"key":"2025032409214271300_r45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jmb.2006.06.009","article-title":"The structure of bovine complement component 3 reveals the basis for thioester function","volume":"361","author":"Fredslund","year":"2006","journal-title":"J. Mol. Biol."},{"key":"2025032409214271300_r46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature05172","article-title":"Structure of C3b reveals conformational changes that underlie complement activity","volume":"444","author":"Janssen","year":"2006","journal-title":"Nature"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/189\/3\/1431\/61725268\/1200946.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/189\/3\/1431\/61725268\/1200946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T04:48:07Z","timestamp":1743050887000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/189\/3\/1431\/7994715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1200946","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8]]},"published":{"date-parts":[[2012,8,1]]}}}